Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1:2021:7722269.
doi: 10.1155/2021/7722269. eCollection 2021.

Positive Association between Triglyceride-Rich Lipoprotein Cholesterol and Diabetes Mellitus in Hypertensive Patients

Affiliations

Positive Association between Triglyceride-Rich Lipoprotein Cholesterol and Diabetes Mellitus in Hypertensive Patients

Wei Zhou et al. Int J Endocrinol. .

Abstract

Background: The association between triglyceride-rich lipoprotein cholesterol (TRL-C) and diabetes mellitus (DM) remains unclear because of limited research and data. The aim of this study was to explore the independent association between TRL-C and DM in hypertensive patients and to examine whether a healthy lifestyle would have an impact on this relationship.

Methods: In this study, data from 13,721 hypertensive patients who were not treated with lipid-lowering drugs were analyzed. TRL-C was calculated from total cholesterol (TC) minus [LDL cholesterol + HDL cholesterol]. DM was defined as fasting plasma glucose of ≥7.0 mmol/L and/or self-reported history of hypoglycemic drug use.

Results: After adjusting for potential confounding factors, the TRL-C was significantly positively associated with elevated DM (odds ratio (OR): 1.73 and 95% confidence interval (CI): 1.54-1.94). In subgroup analysis, a healthy lifestyle (HL) failed to modify the positive association between TRL-C and DM (HL: OR 1.93, 95%CI 1.58-2.36; non-HL: OR 1.72, 95%CI 1.50-1.98; P for interaction = 0.38).

Conclusion: The results showed a positive association between TRL-C and DM in hypertensive patients. A healthy lifestyle failed to diminish the relationship between TRL-C and DM. The novel findings indicate that TRL-C might be a reliable marker of DM and may provide a new strategy for the prevention and treatment of DM.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart of study participants.
Figure 2
Figure 2
Dose-response relationship between the TRL-C and the prevalence of DM. Adjusted for age, sex, BMI, current smoking, current drinking, SBP, DBP, eGFR, history of stroke and CAD, and antihypertensive drugs.
Figure 3
Figure 3
Subgroup analyses of the OR (95% CI) of TRL-C on the prevalence of DM. Adjusted for age, sex, BMI, current smoking, current drinking, SBP, DBP, eGFR, history of stroke and CAD, and antihypertensive drugs, if not be stratified.

References

    1. Introduction: Standards of medical care in diabetes-2020. Diabetes Care . 2020;43:S1–S2. - PubMed
    1. Newman J. D., Schwartzbard A. Z., Weintraub H. S., Goldberg I. J., Berger J. S. Primary prevention of cardiovascular disease in diabetes mellitus. Journal of the American College of Cardiology . 2017;70(7):883–893. doi: 10.1016/j.jacc.2017.07.001. - DOI - PMC - PubMed
    1. Goldberg R. B., Stone N. J., Grundy S. M. The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guidelines on the management of blood cholesterol in diabetes. Diabetes Care . 2020;43(8):1673–1678. doi: 10.2337/dci19-0036. - DOI - PubMed
    1. Ginsberg H. N., Ginsberg H. N., Elam M. B., et al. Effects of combination lipid therapy in type 2 diabetes mellitus. New England Journal of Medicine . 2010;362(17):1563–1574. doi: 10.1056/NEJMoa1001282. - DOI - PMC - PubMed
    1. Pradhan A. D., Paynter N. P., Everett B. M., et al. Rationale and design of the pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes (PROMINENT) study. American Heart Journal . 2018;206:80–93. doi: 10.1016/j.ahj.2018.09.011. - DOI - PubMed

LinkOut - more resources